Clinical Implications of Streptococcus Anginosus Group Infections

The Streptococcus anginosus group (SAG) comprises three closely related species—S. anginosus, S. intermedius and S. constellatus—that normally reside in the oral, gastrointestinal and genitourinary tracts. Although classically regarded as commensals, these organisms have emerged as opportunistic pathogens capable of causing a spectrum of pyogenic infections, including brain and liver abscesses, empyema and bloodstream infections. The clinical presentation varies with host factors, ranging from indolent soft-tissue infections in otherwise healthy individuals to fulminant sepsis in immunocompromised patients. Diagnosis is often hindered by the pleomorphic nature of SAG on culture and by polymicrobial contexts, yet advances in molecular identification have improved species-level resolution. Management typically combines prolonged, targeted antimicrobial therapy—guided by susceptibility testing—and, where necessary, surgical or radiological drainage of abscesses. Mortality rates remain appreciable in deep-seated or disseminated infections, underlining the need for early recognition, multidisciplinary care and further research into virulence determinants and resistance mechanisms to inform global treatment guidelines.

Research from Nature Portfolio

A comprehensive clinical survey has characterised demographics, risk factors and outcomes in over 450 patients with SAG infections. It revealed a broad age distribution with a peak incidence among middle-aged adults and a nearly two-to-one male predominance. Underlying conditions—particularly malignancy and diabetes—were present in nearly half of cases. Species distribution varied by infection site: S. anginosus predominated in urinary and gastrointestinal infections, S. constellatus in respiratory and thoracic collections, and S. intermedius in intracranial and hepatic abscesses. Clinical cure was achieved in the majority, yet ten fatalities underscored the severity of invasive disease. This work provides a foundational epidemiological framework, highlights the importance of species-specific patterns for guiding empirical therapy and supports the integration of rapid molecular diagnostics into routine practice.

Clinical Implications of Streptococcus Anginosus Group Infections publication trend

The graph below shows the total number of articles in clinical implications of streptococcus anginosus group infections across all publications each year (not limited to Nature Index journals).

Technical terms

Streptococcus anginosus group (SAG): A cluster of three related Streptococcus species that are part of the normal human microbiota but can become opportunistic pathogens causing purulent infections.

Abscess: A localized collection of pus within tissue, often requiring both antimicrobial treatment and drainage for resolution.

Bacteremia: The presence of bacteria in the bloodstream, which can lead to systemic inflammatory responses and metastatic infections.

Colonisation: The asymptomatic presence and multiplication of microorganisms on a body surface without causing disease.

References

1. Anovaginal Colonization by Group B Streptococcus and Streptococcus anginosus among Pregnant Women in Brazil and Its Association with Clinical Features. Antibiotics (2024).
2. Clinical features of Streptococcus intermedius infection in children: a case series study. Frontiers in Microbiology (2023).
3. Bacteremia from streptococcus constellatus revealing a gastrointestinal stromal tumor. Gut Pathogens (2024).
4. The Clinical View on Streptococcus anginosus Group – Opportunistic Pathogens Coming Out of Hiding. Frontiers in Microbiology (2022).
5. Clinical Characteristics of Infections Caused by Streptococcus Anginosus Group. Scientific Reports (2020).